{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:14:26Z","timestamp":1787022866270,"version":"build-2736575974"},"reference-count":50,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2024,3,30]]},"DOI":"10.1536\/ihj.23-215","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T18:17:56Z","timestamp":1711736276000},"page":"254-262","source":"Crossref","is-referenced-by-count":3,"title":["Causal Relationship Between Immune Cells\/Cytokines and Dilated Cardiomyopathy"],"prefix":"10.1536","volume":"65","author":[{"given":"Bin","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital, Guangxi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital, Guangxi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital, Guangxi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bo","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital, Guangxi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Gui","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital, Guangxi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","unstructured":"1. Brieler J, Breeden MA, Tucker J. Cardiomyopathy: an overview. Am Fam Phys 2017; 96: 640-6."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lu YW, Wang DZ. Non-coding RNA in ischemic and non-ischemic cardiomyopathy. Curr Cardiol Rep 2018; 20: 115.","DOI":"10.1007\/s11886-018-1055-y"},{"key":"3","first-page":"e579","volume":"134","year":"2016","unstructured":"3. Bozkurt B, Colvin M, Cook J, <i>et al<\/i>. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation 2016; 134: e579-646.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Crea F. The universal definition of heart failure, risk prediction in cardiogenic shock, artificial intelligence in cardiac allograft rejection, and the genetics of dilated cardiomyopathy. Eur Heart J 2021; 42: 2317-20.","DOI":"10.1093\/eurheartj\/ehab370"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lakdawala NK, Winterfield JR, Funke BH. Dilated cardiomyopathy. Circ Arrhythm Electrophysiol 2013; 6: 228-37.","DOI":"10.1161\/CIRCEP.111.962050"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Schultheiss HP, Fairweather D, Caforio ALP, <i>et al<\/i>. Dilated cardiomyopathy. Nat Rev Dis Primers 2019; 5: 32.","DOI":"10.1038\/s41572-019-0084-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Venero JV, Doyle M, Shah M, <i>et al<\/i>. Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy-preliminary observations from a high-volume transplant centre. ESC Heart Fail 2015; 2: 150-9.","DOI":"10.1002\/ehf2.12041"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cojan-Minzat BO, Zlibut A, Agoston-Coldea L. Non-ischemic dilated cardiomyopathy and cardiac fibrosis. Heart Fail Rev 2021; 26: 1081-101.","DOI":"10.1007\/s10741-020-09940-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. McKenna WJ, Maron BJ, Thiene G. Classification, epidemiology, and global burden of cardiomyopathies. Circ Res 2017; 121: 722-30.","DOI":"10.1161\/CIRCRESAHA.117.309711"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hariton E, Locascio JJ. Randomised controlled trials-the gold standard for effectiveness research: study design: randomised controlled trials. BJOG 2018; 125: 1716.","DOI":"10.1111\/1471-0528.15199"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Allen RW, Barn PK, Lanphear BP. Randomized controlled trials in environmental health research: unethical or underutilized? PLOS Med 2015; 12: e1001775.","DOI":"10.1371\/journal.pmed.1001775"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA 2017; 318: 1925-6.","DOI":"10.1001\/jama.2017.17219"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Xia J, Xie SY, Liu KQ, <i>et al<\/i>. Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study. Ann Rheum Dis 2020; 79: 1460-7.","DOI":"10.1136\/annrheumdis-2020-217892"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Miao L, Min Y, Qi B, <i>et al<\/i>. Causal effect between total cholesterol and HDL cholesterol as risk factors for chronic kidney disease: a Mendelian randomization study. BMC Nephrol 2021; 22: 35.","DOI":"10.1186\/s12882-020-02228-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kanai M, Akiyama M, Takahashi A, <i>et al<\/i>. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet 2018; 50: 390-400.","DOI":"10.1038\/s41588-018-0047-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lam M, Chen CY, Li Z, <i>et al<\/i>. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat Genet 2019; 51: 1670-8.","DOI":"10.1038\/s41588-019-0512-x"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Astle WJ, Elding H, Jiang T, <i>et al<\/i>. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell 2016; 167: 1415-29.","DOI":"10.1016\/j.cell.2016.10.042"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Folkersen L, Gustafsson S, Wang Q, <i>et al<\/i>. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab 2020; 2: 1135-48.","DOI":"10.1038\/s42255-020-00287-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Vuckovic D, Bao EL, Akbari P, <i>et al<\/i>. The polygenic and monogenic basis of blood traits and diseases. Cell 2020; 182: 1214-31.","DOI":"10.1016\/j.cell.2020.08.008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Orr\u00f9 V, Steri M, Sidore C, <i>et al<\/i>. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 2020; 52: 1036-45.","DOI":"10.1038\/s41588-020-0684-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zheng J, Baird D, Borges MC, <i>et al<\/i>. Recent developments in Mendelian randomization studies. Curr Epidemiol Rep 2017; 4: 330-45.","DOI":"10.1007\/s40471-017-0128-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hemani G, Zheng J, Elsworth B, <i>et al<\/i>. The MR-Base platform supports systematic causal inference across the human phenome. eLife 2018; 7: e34408.","DOI":"10.7554\/eLife.34408"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lawlor DA. Commentary: two-sample Mendelian randomization: opportunities and challenges. Int J Epidemiol 2016; 45: 908-15.","DOI":"10.1093\/ije\/dyw127"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods 2019; 10: 486-96.","DOI":"10.1002\/jrsm.1346"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O&apos;Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008; 24: 2938-9.","DOI":"10.1093\/bioinformatics\/btn564"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015; 44: 512-25.","DOI":"10.1093\/ije\/dyv080"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Palmer TM, Lawlor DA, Harbord RM, <i>et al<\/i>. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 2012; 21: 223-42.","DOI":"10.1177\/0962280210394459"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013; 37: 658-65.","DOI":"10.1002\/gepi.21758"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40: 304-14.","DOI":"10.1002\/gepi.21965"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol 2017; 46: 1985-98.","DOI":"10.1093\/ije\/dyx102"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Mokry LE, Ross S, Timpson NJ, Sawcer S, Davey Smith G, Richards JB. Obesity and multiple sclerosis: a Mendelian randomization study. PLOS Med 2016; 13: e1002053.","DOI":"10.1371\/journal.pmed.1002053"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Cooke CE. Idiopathic dilated cardiomyopathy. N Engl J Med 1995; 332: 1384.","DOI":"10.1056\/NEJM199505183322015"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Akhtar M, Elliott PM. Risk stratification for sudden cardiac death in non-ischaemic dilated cardiomyopathy. Curr Cardiol Rep 2019; 21: 155.","DOI":"10.1007\/s11886-019-1236-3"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nevers T, Salvador AM, Velazquez F, <i>et al<\/i>. Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure. J Exp Med 2017; 214: 3311-29.","DOI":"10.1084\/jem.20161791"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Legere SA, Haidl ID, L\u00e9gar\u00e9 JF, Marshall JS. Mast cells in cardiac fibrosis: new insights suggest opportunities for intervention. Front Immunol 2019; 10: 580.","DOI":"10.3389\/fimmu.2019.00580"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Bansal SS, Ismahil MA, Goel M, <i>et al<\/i>. Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure. Circ Heart Fail 2017; 10: e003688.","DOI":"10.1161\/CIRCHEARTFAILURE.116.003688"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Abdullah CS, Li Z, Wang X, Jin ZQ. Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy. Int Immunopharmacol 2016; 39: 251-64.","DOI":"10.1016\/j.intimp.2016.07.027"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Aghajanian H, Kimura T, Rurik JG, <i>et al<\/i>. Targeting cardiac fibrosis with engineered T cells. Nature 2019; 573: 430-3.","DOI":"10.1038\/s41586-019-1546-z"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. \u010cih\u00e1kov\u00e1 D, Shi Y, Adhikari B, <i>et al<\/i>. Meeting the challenges of myocarditis: new opportunities for prevention, detection, and intervention-a report from the 2021 National Heart, Lung, and Blood Institute workshop. J Clin Med 2022; 11: 5721.","DOI":"10.3390\/jcm11195721"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Chen Y, Park YB, Patel E, Silverman GJ. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol 2009; 182: 6031-43.","DOI":"10.4049\/jimmunol.0804191"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Miles K, Simpson J, Brown S, Cowan G, Gray D, Gray M. Immune tolerance to apoptotic self is mediated primarily by regulatory B1a cells. Front Immunol 2017; 8: 1952.","DOI":"10.3389\/fimmu.2017.01952"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Tang Q, Cen Z, Lu J, <i>et al<\/i>. The abnormal distribution of peripheral B1 cells and transition B cells in patients with idiopathic dilated cardiomyopathy: a pilot study. BMC Cardiovasc Disord 2022; 22: 78.","DOI":"10.1186\/s12872-022-02461-8"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Bracamonte-Baran W, \u010cih\u00e1kov\u00e1 D. Cardiac autoimmunity: myocarditis. Adv Exp Med Biol 2017; 1003: 187-221.","DOI":"10.1007\/978-3-319-57613-8_10"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Caforio ALP, Pankuweit S, Arbustini E, <i>et al<\/i>. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 2636-48.","DOI":"10.1093\/eurheartj\/eht210"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Pankuweit S, Funck R, Grimm W, Maisch B. [Diagnosis and treatment of inflammatory heart diseases: role of endomyocardial biopsy]. Herz 2006; 31: 361-5.","DOI":"10.1007\/s00059-006-2844-4"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Wu D, Molofsky AB, Liang HE, <i>et al<\/i>. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011; 332: 243-7.","DOI":"10.1126\/science.1201475"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Diny NL, Baldeviano GC, Talor MV, <i>et al<\/i>. Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy. J Exp Med 2017; 214: 943-57.","DOI":"10.1084\/jem.20161702"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Schiechl G, Hermann FJ, Rodriguez Gomez M, <i>et al<\/i>. Basophils trigger fibroblast activation in cardiac allograft fibrosis development. Am J Transplant 2016; 16: 2574-88.","DOI":"10.1111\/ajt.13764"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Kr\u00e4mer LM, Brettschneider J, Lennerz JK, <i>et al<\/i>. Amyloid precursor protein-fragments-containing inclusions in cardiomyocytes with basophilic degeneration and its association with cerebral amyloid angiopathy and myocardial fibrosis. Sci Rep 2018; 8: 16594.","DOI":"10.1038\/s41598-018-34808-7"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Wojciechowska C, Romuk E, Tomasik A, <i>et al<\/i>. Oxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy. Mediators Inflamm 2014; 2014: 147040.","DOI":"10.1155\/2014\/147040"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/2\/65_23-215\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:44:55Z","timestamp":1711759495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/2\/65_23-215\/_article"}},"subtitle":["A Mendelian Randomization Study"],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.23-215","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]},"article-number":"23-215"}}